细胞周期独立的非正规基因向基因的特征和调节
Shinta Saito1, Noritaka Adachi2
1Department of Life and Environmental System Science, Graduate School of Nanobioscience, Yokohama City University, Yokohama, 236-0027, Japan.
Nature communications
|June 18, 2024
概括
在人类细胞中,一种新的基因向机制绕过了对Rad51的需求,利用单链化 (SSA). 这种独立于Rad51的途径即使在G1阶段也活跃,并为精确的基因组修改提供了一条新的途径.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 基因向使精确的基因组修饰成为可能,但其在人类细胞中的机制尚未完全理解.
- 取决于同质性的向DNA整合依赖于同质性重组 (HR).
研究的目的:
- 阐明人类细胞中基因向的基本机制.
- 识别针对性DNA整合的非正规途径.
主要方法:
- 研究的基因向机制独立于同类重组蛋白 (HR) Rad51.1.
- 评估了Rad52和单链回火 (SSA) 在基因向中的作用.
- 分析了DNA双链断裂 (DSB) 修复途径缺陷和特定基因淘汰 (Msh2,BLM) 对整合效率的影响.
- 确定细胞周期对观察到的整合机制的依赖性.
主要成果:
- 确定了一种非正规基因向机制,不需要Rad51.1.
- 证明Rad52抑制抑制了这种机制,这意味着单链化 (SSA).
- 在具有缺陷HR或末端连接修复通路的细胞中,SSA介导的基因向增强.
- 这种SSA途径允许多达5%的序列分离,并且独立于细胞周期,发生在G1阶段.
- Msh2的损失,BLM的损失,以及目标站点的DNA断裂协同增强了SSA介导的整合.
结论:
- 通过SSA在人类细胞中实现Rad51独立的向DNA集成的明确证据.
- 揭示了多个监管机制,管理SSA介导的有针对性和随机集成.
- 这一发现扩大了精确基因组修改的工具包,特别是在具有挑战性的细胞环境中.
相关概念视频
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
The Cell Cycle Control System
2.8K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
2.8K
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


